Literature DB >> 26328165

Predictive values for extracapsular extension in prostate cancer patients with PSA values below 10 ng/mL.

Zülfü Sertkaya1, Metin İshak Öztürk1, Orhan Koca1, Mustafa Güneş1, Muhammet İhsan Karaman1.   

Abstract

OBJECTIVE: We aimed to determine predictive values of extracapsular extension (ECE) in patients who had undergone radical retropubic prostatectomy (RRP) with prostate-specific antigen (PSA) values below 10 ng/mL.
MATERIAL AND METHODS: We retrospectively scanned data of 167 patients with PSA values below 10 ng/mL who had undergone radical retropubic prostatectomy (RRP) between April 2004 and August 2011 in our clinic. Age, PSA, PSA ratio, PSA density, digital rectal examination (DRE) findings, biopsy total Gleason score, perineural invasion (PNI), and lymphovascular invasion (LVI) were analyzed. Parameters of the groups with or without extracapsular extension in RRP pathology specimens were compared.
RESULTS: The mean age of patients was 66.4±12.3 years. According to histopathological analysis of the specimens of RRP of 167 patients, 45 (26.9%) had extracapsular extension (pT3-4) (Group 1); 122 (73.1%) were confined to the prostate (pT2) (Group 2). The mean PSA level was high in Group 1 (p= 0.114), PSA ratio was higher in Group 2 (p=0.09). PSA density was 0.17 in Group 1 and 0.24 in Group 2 (p=0.03). DRE positivity was 53.3% and 57.1%, respectively (p=0.71). Biopsy total Gleason score was higher in Group 1 than Group 2 with a statistically significant difference (p=0.04). A statistically significant difference was found between the rates of PNI and LVI (28.9% and 1.63%, respectively) (p=0.002). There was no statistically significant difference between both groups as for surgical margin positivity (p=0.18).
CONCLUSION: In PCa patients with PSA values below 10 ng/mL, PSA density, lymphovascular invasion and biopsy Gleason total score were statistically significant in predicting extracapsular invasion. Therefore, these results must be considered in preoperative evaluation.

Entities:  

Keywords:  Extracapsular invasion; Gleason score; PSA density; prostate cancer

Year:  2014        PMID: 26328165      PMCID: PMC4548391          DOI: 10.5152/tud.2014.00086

Source DB:  PubMed          Journal:  Turk J Urol        ISSN: 2149-3235


  17 in total

Review 1.  Review of staging modalities in clinically localized prostate cancer.

Authors:  M Perrotti; A Pantuck; F Rabbani; R S Israeli; R E Weiss
Journal:  Urology       Date:  1999-08       Impact factor: 2.649

2.  Cancer statistics, 1990.

Authors:  E Silverberg; C C Boring; T S Squires
Journal:  CA Cancer J Clin       Date:  1990 Jan-Feb       Impact factor: 508.702

3.  Clinical utility of the percentage of positive prostate biopsies in defining biochemical outcome after radical prostatectomy for patients with clinically localized prostate cancer.

Authors:  A V D'Amico; R Whittington; S B Malkowicz; D Schultz; J Fondurulia; M H Chen; J E Tomaszewski; A A Renshaw; A Wein; J P Richie
Journal:  J Clin Oncol       Date:  2000-03       Impact factor: 44.544

4.  The American Cancer Society National Prostate Cancer Detection Project. Findings on the detection of early prostate cancer in 2425 men.

Authors:  C Mettlin; F Lee; J Drago; G P Murphy
Journal:  Cancer       Date:  1991-06-15       Impact factor: 6.860

5.  Percent of cancer in the biopsy set predicts pathological findings after prostatectomy.

Authors:  David J Grossklaus; Christopher S Coffey; Scott B Shappell; Gregory S Jack; Sam S Chang; Michael S Cookson
Journal:  J Urol       Date:  2002-05       Impact factor: 7.450

Review 6.  Staging prostate cancer--1997: current methods and limitations.

Authors:  D G Bostwick
Journal:  Eur Urol       Date:  1997       Impact factor: 20.096

Review 7.  New circulating biomarkers for prostate cancer.

Authors:  K Bensalah; Y Lotan; J A Karam; S F Shariat
Journal:  Prostate Cancer Prostatic Dis       Date:  2007-11-13       Impact factor: 5.554

8.  Mortality results from a randomized prostate-cancer screening trial.

Authors:  Gerald L Andriole; E David Crawford; Robert L Grubb; Saundra S Buys; David Chia; Timothy R Church; Mona N Fouad; Edward P Gelmann; Paul A Kvale; Douglas J Reding; Joel L Weissfeld; Lance A Yokochi; Barbara O'Brien; Jonathan D Clapp; Joshua M Rathmell; Thomas L Riley; Richard B Hayes; Barnett S Kramer; Grant Izmirlian; Anthony B Miller; Paul F Pinsky; Philip C Prorok; John K Gohagan; Christine D Berg
Journal:  N Engl J Med       Date:  2009-03-18       Impact factor: 91.245

9.  Predictive value of prostate-specific antigen density for the presence of micrometastatic carcinoma of the prostate.

Authors:  E K Seaman; I S Whang; W Cooner; C A Olsson; M C Benson
Journal:  Urology       Date:  1994-05       Impact factor: 2.649

10.  Prostate-Specific Antigen Density as a Powerful Predictor of Extracapsular Extension and Positive Surgical Margin in Radical Prostatectomy Patients with Prostate-Specific Antigen Levels of Less than 10 ng/ml.

Authors:  Jin-Seok Chang; Hoon Choi; Young-Seop Chang; Jin-Bum Kim; Mi Mi Oh; Du Geon Moon; Jae Hyun Bae; Jun Cheon
Journal:  Korean J Urol       Date:  2011-12-20
View more
  1 in total

1.  Prognostic Value of Perineural Invasion in Resected Gastric Cancer Patients According to Lauren Histotype.

Authors:  Lorenzo De Franco; Daniele Marrelli; Costantino Voglino; Carla Vindigni; Francesco Ferrara; Giulio Di Mare; Livio Iudici; Mario Marini; Franco Roviello
Journal:  Pathol Oncol Res       Date:  2017-05-30       Impact factor: 3.201

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.